Purchase of Oncotype DX Tests
Details
- Supplier(s)
- EXACT SCIENCES
- Value
- GBP 391,500
- Duration
- 2 years
- Topic
- Clinical products
- Published
- 27 May 2025
- Source
- uk:contracts_finder
Tender description
Purchase of 290 Oncotype DX tests (145 per annum) Awarded to Exact Science via NHSSC - Laboratory Diagnostics, Point of Care Testing and Pathology Managed Service 2023/S 000-028831 Total cost = £391,500.00 Exc. VAT (£155,250.00 exc VAT per annum) Period - 01/04/2025 - 31/03/2027
Timeline
- Completed: Award date1 April 2025
- Completed: Award published27 May 2025Current notice
- Next: Contract expiry date31 March 2027in 7 months
About the buyer
GATESHEAD HEALTH NHS FOUNDATION TRUST is a public sector buyer in United Kingdom publishing tenders and awards on Stotles. Explore their procurement activity and find more opportunities like this one.
Relevant CPV codes
- 33698000 · Clinical products
Decision makers
Connect with the people behind this procurement.
| Contact name | Job title | Phone number | Work email |
|---|---|---|---|
| Head of Procurement | +44 •••• •••••• | ••••••••@gateshead-health-nhs-foundation-trust.gov | |
| Commercial Director | +44 •••• •••••• | ••••••••@gateshead-health-nhs-foundation-trust.gov | |
| Procurement Manager | +44 •••• •••••• | ••••••••@gateshead-health-nhs-foundation-trust.gov | |
| Category Lead | +44 •••• •••••• | ••••••••@gateshead-health-nhs-foundation-trust.gov | |
| Senior Buyer | +44 •••• •••••• | ••••••••@gateshead-health-nhs-foundation-trust.gov | |
| Contracts Manager | +44 •••• •••••• | ••••••••@gateshead-health-nhs-foundation-trust.gov |
1 similar open tenders
See more open tenders related to Purchase of Oncotype DX Tests.
- Open tender
MEDICAL TECHNOLOLGY (MEDTECH) INNOVATION DPS
Related buyers
Buyers similar to GATESHEAD HEALTH NHS FOUNDATION TRUST.
- 514£239.2m
- 381£5.3bn
- 321£279.9m
- 262£44.9m
- 244£140.9m
- 231£25.7m
- 229£225.2m
- 220£11.8m
- 209£131.5m
- 178£11.5bn
Win more public sector contracts
Track every UK and Ireland tender in one place — set up alerts, find decision-makers, and never miss an opportunity.
